Dr. McDermott on Immunotherapy as a Standard of Care in RCC OncLive 0:54 6 years ago 129 Далее Скачать
Dr. McDermott on Single-Agent Pembrolizumab in Advanced RCC OncLive 1:58 5 years ago 263 Далее Скачать
Dr. McDermott on Major Findings of Efficacy and Safety of Nivolumab in RCC OncLive 1:22 8 years ago 207 Далее Скачать
Watch Drs. Choueiri, McDermott, and Tannir, discuss the latest in RCC: https://bit.ly/3n3X59m PeerView Oncology 1:05:38 4 years ago 143 Далее Скачать
Dr. McDermott on Single-Agent Versus Combination Immunotherapy in RCC OncLive 1:15 5 years ago 110 Далее Скачать
Dr. McDermott on an Analysis of the CheckMate-214 Study in RCC OncLive 1:38 6 years ago 177 Далее Скачать
Dr. McDermott on the Promise of Pembrolizumab in Non-Clear Cell RCC OncLive 1:10 5 years ago 92 Далее Скачать
Dr. McDermott on Toxicities of Immunotherapy Combinations in RCC OncLive 1:16 4 years ago 78 Далее Скачать
Dr. McDermott Discusses the Future of Immune Checkpoints in RCC OncLive 1:23 7 years ago 72 Далее Скачать
